Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 30% ± 8% | |
lung | 5 studies | 23% ± 5% | |
lymph node | 4 studies | 28% ± 10% | |
brain | 4 studies | 29% ± 9% | |
intestine | 3 studies | 23% ± 3% | |
bone marrow | 3 studies | 25% ± 6% | |
prostate | 3 studies | 20% ± 2% | |
uterus | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1942.36 | 575 / 578 | 98% | 11.00 | 1133 / 1155 |
breast | 94% | 1098.58 | 432 / 459 | 98% | 11.55 | 1099 / 1118 |
uterus | 99% | 2978.27 | 168 / 170 | 90% | 10.50 | 413 / 459 |
intestine | 97% | 1553.43 | 935 / 966 | 90% | 8.58 | 473 / 527 |
bladder | 100% | 1547.38 | 21 / 21 | 85% | 8.70 | 427 / 504 |
prostate | 98% | 1333.06 | 240 / 245 | 87% | 5.50 | 435 / 502 |
ovary | 100% | 1656.55 | 180 / 180 | 82% | 5.40 | 353 / 430 |
thymus | 89% | 831.12 | 584 / 653 | 92% | 6.17 | 554 / 605 |
esophagus | 79% | 1130.60 | 1137 / 1445 | 96% | 10.67 | 176 / 183 |
adrenal gland | 97% | 1157.29 | 249 / 258 | 69% | 9.22 | 158 / 230 |
stomach | 71% | 1165.40 | 256 / 359 | 93% | 10.68 | 265 / 286 |
brain | 42% | 307.75 | 1106 / 2642 | 97% | 12.01 | 686 / 705 |
kidney | 42% | 428.02 | 37 / 89 | 88% | 10.54 | 789 / 901 |
skin | 48% | 1819.22 | 862 / 1809 | 68% | 6.31 | 322 / 472 |
pancreas | 14% | 89.31 | 45 / 328 | 93% | 12.07 | 165 / 178 |
blood vessel | 100% | 6098.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.06 | 29 / 29 |
spleen | 100% | 2948.57 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.53 | 1 / 1 |
peripheral blood | 99% | 4557.14 | 918 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 1417.18 | 1188 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 6.96 | 41 / 45 |
liver | 15% | 94.24 | 34 / 226 | 49% | 4.08 | 199 / 406 |
heart | 59% | 563.77 | 508 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.21 | 6 / 80 |
muscle | 3% | 16.69 | 24 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005615 | Cellular component | extracellular space |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | GLIPR1 |
Protein name | GLI pathogenesis related 1 (cDNA FLJ50386, highly similar to Glioma pathogenesis-related protein 1) Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1) GLI pathogenesis related 1 |
Synonyms | RTVP1 GLIPR |
Description | |
Accessions | J3QTC9 ENST00000536703.5 P48060 F6VVE8 ENST00000550491.1 ENST00000266659.8 [P48060-1] ENST00000456650.7 B4E3S5 |